tumor, 12
DM, 8
tumour, 6
Atm-deficient, 4
VHL, 4
WAS, 3
cancer, 2
PAH-deficient, 2
hereditary breast and ovarian cancer, 2
CHD, 2
APC, 2
breast-ovarian cancer, 2
breast or ovarian cancer, 2
HPRT-deficient, 2
C6-deficient, 1
prostatic adenocarcinoma, 1
APRT-HPRT-deficient, 1
inherited breast cancer, 1
breast / ovarian cancer, 1
ACG1B, 1
breast cancer, 1
multiple endocrine neoplasia ( MEN ) types 1 and 2, 1
familial breast cancer, 1
familial aniridia, 1
colorectal cancer, 1
hereditary breast cancer, 1
A-T, 1
prostate adenocarcinoma, 1
AT, 1
inherited breast / ovarian cancer, 1
hereditary breast or ovarian cancer, 1
HPRT-APRT-deficient, 1
male breast cancer, 1
MEN2, 1
breast and 79 ovarian cancer, 1
insulin-dependent diabetes mellitus, 1
adenomatous polyposis coli, 1
G6PD deficient, 1
MEN1, 1
C7-deficient, 1
pancreatic tumour, 1
ovarian cancer, 1
von Willebrand, 1
breast and ovarian cancer, 1
